Published in Med Sci Monit on November 01, 2009
Infant hearing loss: from diagnosis to therapy Official Report of XXI Conference of Italian Society of Pediatric Otorhinolaryngology. Acta Otorhinolaryngol Ital (2012) 1.57
Swept-sine noise-induced damage as a hearing loss model for preclinical assays. Front Aging Neurosci (2015) 0.81
Effects of noise exposure on catalase activity of growing lymphocytes. Bosn J Basic Med Sci (2011) 0.81
Dietary supplement comprised of β-carotene, vitamin C, vitamin E, and magnesium: failure to prevent music-induced temporary threshold shift. Audiol Neurotol Extra (2016) 0.75
Post-processing analysis of transient-evoked otoacoustic emissions to detect 4 kHz-notch hearing impairment--a pilot study. Med Sci Monit (2011) 0.75
Dietary supplementation of coenzyme Q10 plus multivitamins to hamper the ROS mediated cisplatin ototoxicity in humans: A pilot study. Heliyon (2017) 0.75
Work-Related Noise Exposure in a Cohort of Patients with Chronic Tinnitus: Analysis of Demographic and Audiological Characteristics. Int J Environ Res Public Health (2017) 0.75
Percutaneous translaryngeal versus surgical tracheostomy: A randomized trial with 1-yr double-blind follow-up. Crit Care Med (2005) 1.80
Video-assisted thyroidectomy significantly reduces the risk of early postthyroidectomy voice and swallowing symptoms. World J Surg (2008) 1.72
Voice and swallowing changes after thyroidectomy in patients without inferior laryngeal nerve injuries. Surgery (2006) 1.46
Autoimmunity in sudden sensorineural hearing loss: possible role of anti-endothelial cell autoantibodies. Acta Otolaryngol Suppl (2002) 1.40
Pathogenesis of presbycusis in animal models: a review. Exp Gerontol (2011) 1.29
Postlaryngectomy pharyngocutaneous fistula: incidence, predisposing factors, and therapy. Otolaryngol Head Neck Surg (2005) 1.26
Trafficking and postsecretory events responsible for the formation of secreted human salivary peptides: a proteomics approach. Mol Cell Proteomics (2008) 1.26
Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment. J Voice (2007) 1.22
Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Eur J Cancer (2005) 1.21
CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol (2007) 1.15
Water-soluble Coenzyme Q10 formulation (Q-ter) promotes outer hair cell survival in a guinea pig model of noise induced hearing loss (NIHL). Brain Res (2008) 1.14
Long-term outcome of functional post-thyroidectomy voice and swallowing symptoms. Surgery (2009) 1.11
Noise-induced hearing loss (NIHL) as a target of oxidative stress-mediated damage: cochlear and cortical responses after an increase in antioxidant defense. J Neurosci (2013) 1.07
HPLC-ESI-MS analysis of oral human fluids reveals that gingival crevicular fluid is the main source of oral thymosins beta(4) and beta(10). J Sep Sci (2009) 1.02
Too much of a good thing: long-term treatment with salicylate strengthens outer hair cell function but impairs auditory neural activity. Hear Res (2010) 1.02
Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas. Clin Cancer Res (2007) 1.02
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? Radiother Oncol (2012) 0.99
Comparison of total laryngectomy with surgical (cricohyoidopexy) and nonsurgical organ-preservation modalities in advanced laryngeal squamous cell carcinomas: A multicenter retrospective analysis. Head Neck (2012) 0.98
Detection in human saliva of different statherin and P-B fragments and derivatives. Proteomics (2006) 0.96
Defective one- or two-electron reduction of the anticancer anthracycline epirubicin in human heart. Relative importance of vesicular sequestration and impaired efficiency of electron addition. J Biol Chem (2006) 0.95
Residual hearing in cochlear implant patients. Eur Arch Otorhinolaryngol (2007) 0.95
Comparison of salicylate- and quinine-induced tinnitus in rats: development, time course, and evaluation of audiologic correlates. Otol Neurotol (2010) 0.94
Value of fine-needle aspiration cytology of parotid gland masses. Laryngoscope (2004) 0.94
"One-shot" CO2 versus Er:YAG laser stapedotomy: is the outcome the same? Eur Arch Otorhinolaryngol (2010) 0.94
Aural acquired cholesteatoma in children: surgical findings, recurrence and functional results. Int J Pediatr Otorhinolaryngol (2006) 0.94
Damage to ciliated epithelium in chronic rhinosinusitis: what is the role of bacterial biofilms? Ann Otol Rhinol Laryngol (2008) 0.93
Doxorubicin-derived metabolites induce release of cytochrome C and inhibition of respiration on cardiac isolated mitochondria. Anticancer Res (2003) 0.93
Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage. Hear Res (2003) 0.93
Head and neck squamous cell carcinoma: role of the human papillomavirus in tumour progression. New Microbiol (2006) 0.92
Sudden onset sensorineural hearing loss caused by meningeal carcinomatosis secondary to occult malignancy: report of two cases. Auris Nasus Larynx (2009) 0.92
A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population. BMC Cancer (2009) 0.91
Seminal antioxidant capacity in pre- and postoperative varicocele. J Androl (2003) 0.91
beta-carotene supplementation in patients radically treated for stage I-II head and neck cancer: results of a randomized trial. Oncol Rep (2003) 0.91
Electric to acoustic pitch matching: a possible way to improve individual cochlear implant fitting. Eur Arch Otorhinolaryngol (2008) 0.91
Serum fatty acids and cardiovascular risk factors in sudden sensorineural hearing loss: a case-control study. Ann Otol Rhinol Laryngol (2010) 0.91
Bilirubin and S-nitrosothiols interaction: evidence for a possible role of bilirubin as a scavenger of nitric oxide. Biochem Pharmacol (2003) 0.90
Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma. Cancer Chemother Pharmacol (2010) 0.90
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations. Mov Disord (2009) 0.90
VEMPs and dynamic posturography after intratympanic gentamycin in Menière's disease. J Vestib Res (2005) 0.90
Association of laryngeal cancer with previous gastric resection. Ann Surg (2004) 0.89
Protective properties of idebenone in noise-induced hearing loss in the guinea pig. Neuroreport (2006) 0.89
Current trends in paediatric tracheostomies. Int J Pediatr Otorhinolaryngol (2007) 0.89
Salivary glutathione and uric acid levels in patients with head and neck squamous cell carcinoma. Head Neck (2007) 0.89
Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population. Radiother Oncol (2009) 0.89
Lack of association between inherited thrombophilic risk factors and idiopathic sudden sensorineural hearing loss in Italian patients. Ann Otol Rhinol Laryngol (2006) 0.89
Docetaxel and vinorelbine: an effective regimen in recurrent squamous cell esophageal carcinoma. Med Oncol (2003) 0.88
Biliary laryngopharyngeal reflux: a new pathological entity. Curr Opin Otolaryngol Head Neck Surg (2006) 0.88
Stage III-IV sinonasal and nasal cavity carcinoma treated with three-dimensional conformal radiotherapy. Tumori (2008) 0.88
Radiofrequency inferior turbinate reduction: long-term olfactory and functional outcomes. Otolaryngol Head Neck Surg (2011) 0.87
The platysma myocutaneous flap (PMF) for head and neck reconstruction: a retrospective and multicentric analysis of 91 T1-T2 patients. J Craniomaxillofac Surg (2012) 0.87
Vestibular evoked myogenic potentials in children. Int J Pediatr Otorhinolaryngol (2006) 0.87
Upper airway surgery of obstructive sleep apnea in pycnodysostosis: case report and literature review. Am J Med Genet A (2014) 0.87
Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population. Strahlenther Onkol (2010) 0.87
Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. Head Neck (2009) 0.86
alpha-Tocopherol protective effects on gentamicin ototoxicity: an experimental study. Int J Audiol (2004) 0.86
Oncologic results of the surgical salvage of recurrent laryngeal squamous cell carcinoma in a multicentric retrospective series: emerging role of supracricoid partial laryngectomy. Head Neck (2014) 0.86
Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia. Int J Clin Oncol (2012) 0.85
Postoperative dysphagia versus neurogenic dysphagia: scintigraphic assessment. Ann Otol Rhinol Laryngol (2003) 0.85
Clinical and biological prognostic factors in 179 cases with sinonasal carcinoma treated in the Italian Piedmont region. Oncology (2009) 0.85
Sudden sensorineural hearing loss: our experience in diagnosis, treatment, and outcome. J Otolaryngol (2005) 0.85
Coenzyme Q 10 and cardiovascular risk factors in idiopathic sudden sensorineural hearing loss patients. Otol Neurotol (2007) 0.85
Postoperative adjuvant chemoradiotherapy in older patients with head and neck cancer. Arch Otolaryngol Head Neck Surg (2004) 0.85
Endoscopic transsphenoidal approach versus microscopic approach in children. Int J Pediatr Otorhinolaryngol (2011) 0.85
13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group. Oncol Rep (2004) 0.84
Ex vivo gene therapy using autologous dermal fibroblasts expressing hLMP3 for rat mandibular bone regeneration. Head Neck (2010) 0.84
Differences between electrode-assigned frequencies and cochlear implant recipient pitch perception. Acta Otolaryngol (2007) 0.84
Functional and psychological evaluation after flap reconstruction plus radiotherapy in oral cancer. Head Neck (2011) 0.84
Improving melody recognition in cochlear implant recipients through individualized frequency map fitting. Eur Arch Otorhinolaryngol (2010) 0.84
Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium. Eur J Epidemiol (2013) 0.84
Endoscopic endonasal transsphenoidal surgery for sellar tumors in children. Int J Pediatr Otorhinolaryngol (2010) 0.84
Erbium: yttrium-aluminum-garnet laser stapedotomy--a safe technique. Otolaryngol Head Neck Surg (2008) 0.83
Curcuma longa (curcumin) decreases in vivo cisplatin-induced ototoxicity through heme oxygenase-1 induction. Otol Neurotol (2014) 0.83
Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer. New Microbiol (2013) 0.83
Protective effects of alpha-tocopherol against gentamicin-induced Oto-vestibulo toxicity: an experimental study. Acta Otolaryngol (2003) 0.83
Total antioxidant capacity in patients with varicoceles. Fertil Steril (2003) 0.83
Age-dependent modifications of expression level of VEGF and its receptors in the inner ear. Exp Gerontol (2004) 0.82
Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival? Curr Opin Otolaryngol Head Neck Surg (2008) 0.82
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment. Radiol Med (2014) 0.82